(Q58427262)
Statements
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402 (English)
John Sleasman
Terry Fenton
Audra Deveikis
Diane Wara
Russ Van Dyke
Pediatric Aids Clinical Trials Study 402 team
5 April 2007